Edwards Lifesciences Corporation ( EW) - Key Metrics
EW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.70 | $0.16 | ? | ? |
| 2025Q3 | $2.66 | $0.50 | $0.98 | $0.88 |
| 2025Q2 | $2.61 | $0.56 | $0.49 | $0.41 |
| 2025Q1 | $2.41 | $0.61 | $0.48 | $0.38 |
EW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 135.63 |
| 2025Q3 | ? | 39.05 |
| 2025Q2 | ? | 34.80 |
| 2025Q1 | ? | 29.71 |
EW Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 0.71% | ? |
| 2025Q3 | 1.14% | ? |
| 2025Q2 | 0.52% | ? |
| 2025Q1 | 0.53% | ? |
EW
Price: $84.37
52 week price:
Earnings Per Share: 1.85 USD
P/E Ratio: 43.90
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 2.2 million
Ebitda: 328.1 millionMarket Capitalization: 54.3 billion